| abstract |
REFERRING TO A PHARMACEUTICAL FORMULATION THAT INCLUDES: a) FROM 1 MG / ML TO 200 MG / ML OF AN ANTIBODY THAT IS BINDING TO OX40L AND CONTAINS A Fc PART OF HUMAN ORIGIN SUCH AS huMAb OX40L, b) FROM 1 mM TO 100 Mm OF A BUFFER SUCH AS CITRATE OR L-HISTIDINE HCl BUFFER, c) FROM 0.001% TO 1% OF A SURFACTANT SUCH AS POLYSORBATE 20, d) FROM 10 mM TO 500 mM OF A STABILIZING AGENT OR 10 mM TO 500 mM OF AN AGENT STABILIZER AND FROM 5 mM TO 500 mM OF A TONING AGENT OR 5 mM TO 500 mM OF A TONING AGENT AT A pH OF BETWEEN 4.0 AND 7.0. SUCH FORMULATION IS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES SUCH AS ASTHMA, RHEUMATOID ARTHRITIS, ALLERGY, AMONG OTHERS |